Less Risky Blood Thinner Shows Promise

Daiichi Sankyo shows edoxaban to prevent new clots as well as current generic medicine as well as shows less bleeding in patients.

Less Risky Blood Thinner Shows Promise

Edoxaban shows to significantly reduce bleeding in patients who suffer from blood clots. Daiichi Sankyo, a Japanese pharmaceutical company, completed a study including 8,240 patients giving them a once a day edoxaban. The study concluded edoxaban to be a less risky blood thinner showing promise by accomplishing preventing new blood clots in patients just as […]

1 539 540 541